eli lilly tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Tops Semaglutide for Weight

Significant weight loss, through an effect to reduce energy intake, led to the approval of liraglutide (3.0 mg) for the treatment of obesity, an indication currently under investigation with semaglutide

Individual variation is significant: genetic differences in GLP1R sensitivity and dopamine pathway function influence who experiences sleep disruption and who does not

Ipamorelin (Novo Nordisk) is the selective pentapeptide: ~13 GH elevation, with no increase in cortisol or prolactin even at 200 the ED50 GH (Raun 1998)

El futuro del tratamiento de la obesidad reside en la integracin de intervenciones farmacolgicas, conductuales y psicolgicas dentro de un equipo transdisciplinario (endocrinos, dietistas, psiclogos y especialistas en Ciencias de la Actividad Fsica y del deporte entrenador Consejo COLEF COPLEF de Madrid)